Skip to content
Trending
October 19, 2025CEOs of Wells Fargo and Pfizer caution the U.S. could lose its edge to China without innovation June 1, 2025This is why Jamie Dimon is always so gloomy on the economy November 12, 2025Lawmakers just released a much-awaited crypto market structure bill. Here’s what it means for digital assets and what comes next November 23, 2025Bessent believes there won’t be a recession in 2026 but says some sectors are challenged February 2, 2025FAA to restrict helicopter traffic around D.C. airport after fatal airplane collision March 10, 2025Here’s where the jobs are for February 2025 – in one chart November 10, 2025Nexperia parent shares jump 6% as Beijing signals thaw in tensions with Netherlands September 9, 2025T. Rowe Price shares jump after deal where Goldman will invest $1 billion in asset manager February 26, 2025Lucid CEO steps down; EV maker plans to more than double production in 2025 February 26, 2025Consumer prices rise 0.5% in January, higher than expected as annual rate rises to 3%
  Wednesday 10 December 2025
everydayread.net
  • HOME
  • Bitcoin
  • Business
  • Earnings
  • Economy
  • Finance
everydayread.net
everydayread.net
  • HOME
  • Bitcoin
  • Business
  • Earnings
  • Economy
  • Finance
everydayread.net
  Earnings  Walgreens tops estimates as drugstore chain cuts costs, prepares to go private
Earnings

Walgreens tops estimates as drugstore chain cuts costs, prepares to go private

AdminAdmin—April 8, 20250

More stories

Broadcom’s stock pops on mystery $10 billion AI customer

September 15, 2025

MongoDB plummets nearly 27% for worst day ever as weak outlook overshadows strong quarterly results

April 1, 2025

HP sinks 15% as company misses on earnings, guidance due to ‘added cost’ from tariffs

June 24, 2025

Atlassian closes at highest since 2022 after reporting better-than-expected earnings, revenue outlook

February 3, 2025

A sign for US drugstore chain Walgreens is displayed outside its store in New York City on March 7, 2025.

Angela Weiss | AFP | Getty Images

Walgreens on Tuesday reported fiscal second-quarter earnings and revenue that topped expectations, as the retail drugstore giant benefits from cost cuts and prepares to go private.

The company is in the process of being taken private by Sycamore Partners in a deal that is expected to close in the fourth quarter of this year.

Here’s what Walgreens reported for the three-month period ended Feb. 28 compared with what Wall Street was expecting, based on a survey of analysts by LSEG:

  • Earnings per share: 63 cents adjusted vs. 53 cents expected
  • Revenue: $38.59 billion vs. $38 billion expected

This story is developing. Please check back for updates.

Fake job seekers are flooding U.S. companies that are hiring for remote positions, tech CEOs say
CEOs think the U.S. is ‘probably in a recession right now,’ says BlackRock’s Larry Fink
Related posts
  • Related posts
  • More from author
Earnings

Nvidia partner Foxconn reports 26% revenue spike as AI boom continues

December 9, 20250
Earnings

Southwest Airlines cuts outlook on government shutdown demand hit, higher fuel costs

December 8, 20250
Earnings

HPE CEO Neri pleased with quarter despite AI revenue delays as stock bounces from post-earnings dip

December 7, 20250
Load more
Read also
Finance

The Fed decision is expected to feature a rate cut and a lot more. Here’s what to expect

December 9, 20250
Economy

Euro zone inflation up a notch to 2.2% in November, flash data shows

December 9, 20250
Earnings

Nvidia partner Foxconn reports 26% revenue spike as AI boom continues

December 9, 20250
Business

Eli Lilly to build $6 billion manufacturing plant in Alabama to help make upcoming obesity pill, other drugs

December 9, 20250
Finance

SoFi’s stock drops on $1.5 billion share sale announcement

December 8, 20250
Economy

November private payrolls unexpectedly fell by 32,000, led by steep small business job cuts, ADP reports

December 8, 20250
Load more
    © 2022, All Rights Reserved.
    • About Us
    • Advertise With Us
    • Contact Us
    • Disclaimer
    • Cookie Law
    • Privacy Policy
    • Terms & Conditions